FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

929360021000036102: Trade product reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288221000168111 TP (trade product) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507171000036115 Trade product reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507181000036118 Trade product reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351511000168111 <p>Terminology to describe in a health record the product (medication) brand name or the grouping of products into a &quot;family&quot;, for either single component products or components of multi-component products.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


12633 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trade product reference set Developed by Australian Digital Health Agency true Inferred relationship Some 482977627
Trade product reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1231938152
Trade product reference set Is a Simple type reference set true Inferred relationship Some

Members
Bupredermal
Buprenorphine (AUP)
Buprenorphine (Juno)
Buprenorphine (SDZ)
Buprenorphine (SZ)
Buprenorphine (Sandoz)
Buprenorphine/Naloxone 0.7/0.18 (MPL)
Buprenorphine/Naloxone 1.4/0.36 (MPL)
Buprenorphine/Naloxone 11.4/2.9 (MPL)
Buprenorphine/Naloxone 2.9/0.71 (MPL)
Buprenorphine/Naloxone 5.7/1.4 (MPL)
Buprenorphine/Naloxone 8.6/2.1 (MPL)
Buprespan
Bupretec
Bupropion (RL)
Burinex
Burn and Bite (Amcal)
Buscopan
Buscopan Forte
Buspar
Busulfan (Accord)
Busulfan (Apo)
Busulfan (Apotex)
Busulfex
Butafen
Butalgin
Butamol
Buvidal Monthly
Buvidal Weekly
Bydureon
Bydureon BCise
Byetta
C Plus (Nutrition Care)
C-Flox
C-Zine (Amcal)
C-Zine (Chemists' Own)
C-Zine (Guardian)
C20 (Cannatrek)
CAPD/DPCA 17 Sleep Safe
CBD (Satipharm)
CDA CBD
CMV Immunoglobulin-VF (CSL)
CT Plus +
Cabaser
Cabazitaxel (Accord)
Cabazitaxel (Ever Pharma)
Cabazitaxel (Juno)
Cabazitaxel (MSN)
Cabazitaxel (Sanofi)
Cabazitaxel (Winthrop)
Cabenuva
Cabenuva Cabotegravir
Cabenuva Rilpivirine
Cabergoline (Apo)
Cabergoline (Apotex)
Cabergoline (GenRx)
Cablivi
Cabometyx
Cadatin 10/10
Cadatin 10/20
Cadatin 10/40
Cadatin 10/80
Cadatin 5/10
Cadatin 5/20
Cadatin 5/40
Cadatin 5/80
Cadivast 10/10
Cadivast 10/20
Cadivast 10/40
Cadivast 10/80
Cadivast 5/10
Cadivast 5/20
Cadivast 5/40
Cadivast 5/80
Caduet 10/10
Caduet 10/20
Caduet 10/40
Caduet 10/80
Caduet 5/10
Caduet 5/20
Caduet 5/40
Caduet 5/80
Caelyx
Cafergot
Cafergot S
Cafex
Cafnea
Cal Sup
Cal-500
Cal-600
Cal-600 plus D
Cal-Care
Calamari Gold (Bioglan)
Calamine (David Craig)
Calamine (Faulding)
Calamine (Gold Cross)
Calamine (Orion)
Calamine (PharmAust Manufacturing)
Calamine (Sanofi-Aventis)
Calamine APF (extemporaneous)
Calamine Aqueous (David Craig)

Start Previous Page 19 of 127 Next End


Reference Sets

Reference set descriptor

Description inactivation indicator reference set

Back to Start